Clinical Trials Browser

Active not recruiting × OTHER × Hereditary Sensory and Autonomic Neuropathies × Clear all

NCT04520269 2025-09-25

A Single Arm, Phase Ib/II Trial of Single Agent Pacritinib in Patients With 1q21.3 Amplified Solid Tumors Enriching for Interleukin-1 Receptor-associated Kinase 1 Pathway Activation (PAIR)

Phase 1/2 Active not recruiting

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT04163419 2024-03-13

Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis

Phase 2 Active not recruiting

Schwannomatosis, Neurilemmoma, Hereditary Sensory and Autonomic Neuropathies, Pain